Atlas Trials

Rivastigmine for Intensive Care Unit (ICU) Delirium

Clinical trial NCT00704301 · TERMINATED

Trial details

NCT number
NCT00704301
Sponsor
UMC Utrecht
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Delirium
Start date
2008-11-01
Primary completion
2010-04-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.